European Market Report for Implantable Ports 2017 - MedCore

European Market Report for Implantable Ports 2017 - MedCore

  • November 2016 •
  • 134 pages •
  • Report ID: 4353007 •
  • Format: PDF
Description
Implantable ports are reservoirs that are implanted into the body and connected to the superior vena cava (SVC) by a catheter. These devices require an invasive surgical implantation by vascular surgeons or interventional radiologists. Ports provide long-term treatment ranging from several months to several years. There are implantable ports for the torso and the arms; however, the arm port market is limited by its history of technical problems. Patients undergoing long-term treatments often opt for implantable ports, as the devices are less visible, more comfortable and more convenient than chronic central venous catheters (CVCs) or peripherally inserted central catheters (PICCs). Depending on treatment, patients with certain models of implantable ports can receive a constant flow of medication, or a single large dose on a regular basis. In addition, implantable ports are associated with several benefits including fewer complications, a lower infection risk in comparison to CVCs and PICCs, as well as a higher level of patient satisfaction. However, infections and other complications remain a serious concern. Moreover, from the three main venous access devices: CVCs, PICCs and ports, ports are the most expensive device and require a more complicated insertion procedure.
Abstract
The implantable port market comprises conventional and power-injectable implantable ports. Power-injectable implantable ports are capable of withstanding higher pressures than conventional implantable ports in order to facilitate the injection of contrast dye for computed tomography (CT) scan procedures. If a patient has a conventional implantable port and requires a medical scan, the port must be removed and replaced with a power-injectable port.
Scope:2013-2023
Companies
3DT Holdings LLC
3M
Access Scientific
Ambu Inc.
AngioDynamics
Artsana
B. Braun
Baxter International
Becton Dickinson
Bionic
C. R. Bard
Cardinal Health
CareFusion
Codan
Cook Medical
Covidien
Deltamed
Districlass Medical
Edwards Lifesciences
Endeavor Capital
Fresenius
Grupo Sendal
Interrad Medical
Investindustrial
Ivera Medical Corporation
Joline
Kimal
LPI
Medcomp
Medikit
Medtronic
Navilyst Medical
Nipro Medical
Nostix, LLC
Novico
Pentaferte
Perouse Medical
PFM Medical
PFM Medical
PositiveID Corp.
Rays
Romedex
Roundtable Healthcare
Safety Syringes Inc.
Semprus BioSciences
Smiths Medical
SonoSite, Inc.
Teleflex Medical
Terumo
Troge
Vascular Pathways, Inc.
VeriTeQ Acquisition Corp.
VigMed
V-Tech
Vygon